UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000009972 |
|---|---|
| Receipt number | R000011658 |
| Scientific Title | Usefulness of EUS-FNA for GI tract submucosal tumor |
| Date of disclosure of the study information | 2013/02/11 |
| Last modified on | 2024/08/15 16:16:41 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Usefulness of EUS-FNA for GI tract submucosal tumor
Acronym
EUS-FNA for GI tract SMT
Scientific Title
Usefulness of EUS-FNA for GI tract submucosal tumor
Scientific Title:Acronym
EUS-FNA for GI tract SMT
Region
| Japan |
Condition
Condition
GI tract submucosal tumor
Classification by specialty
| Medicine in general | Gastroenterology | Gastrointestinal surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Diagnostic accuracy
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Diagnostic accuracy
Complication
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Hypoechoic solid tumor
Submucosa to extraluminal
Key exclusion criteria
Bleeding tendency
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Kazuya |
| Middle name | |
| Last name | Akahoshi |
Organization
Aso Iizuka Hospital
Division name
Gastroenterology
Zip code
820-8505
Address
Yoshio3-83, Iizuka, Japan
TEL
0948223800
kakahoshi2@aol.com
Public contact
Name of contact person
| 1st name | Kazuya |
| Middle name | |
| Last name | Akahshi |
Organization
Aso Iizuka Hospital
Division name
Gastroenterology
Zip code
820-8505
Address
Yoshio 3-83, Iizuka, Japan
TEL
0948223800
Homepage URL
kakahoshi2@aol.com
Sponsor or person
Institute
Aso Iizuka Hospital
Institute
Department
Personal name
Funding Source
Organization
Department of Medical Research Promotion, Aso Iizuka Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical board of Iizuka Hospital
Address
Yoshio3-83, Iizuka, Japan
Tel
0948223800
rinri@aih-net.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 02 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
508
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2002 | Year | 09 | Month | 01 | Day |
Date of IRB
| 2006 | Year | 05 | Month | 09 | Day |
Anticipated trial start date
| 2002 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2030 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The collection rate
of adequate specimens from the GI tract subepithelial
hypoechoic tumor with continuity to proper muscle
layer was 82%
Management information
Registered date
| 2013 | Year | 02 | Month | 05 | Day |
Last modified on
| 2024 | Year | 08 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011658
